These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 4828816
21. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings. Pearson RM, Griffith DN, Woollard M, James IM, Havard CW. Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401 [Abstract] [Full Text] [Related]
22. Individual titration of diazoxide dosage in the treatment of severe hypertension. Ram CV, Kaplan NM. Am J Cardiol; 1979 Mar; 43(3):627-30. PubMed ID: 420113 [Abstract] [Full Text] [Related]
23. Treatment of hypertension in infancy with diazoxide: report of a case with arrhythmia as a complications of therapy. Mauer SM, Mirkin BL. J Pediatr; 1972 Apr; 80(4):657-9. PubMed ID: 5015079 [No Abstract] [Full Text] [Related]
24. Use of diazoxide for refractory hypertension. Case reports. Edwards JC. Mo Med; 1974 Aug; 71(8):498-502. PubMed ID: 4845541 [No Abstract] [Full Text] [Related]
25. Dangers of diazoxide. Michael CA. Br Med J; 1972 Dec 16; 4(5841):669. PubMed ID: 4645909 [No Abstract] [Full Text] [Related]
26. Vasodilator drugs in the treatment of hypertension. Koch-Weser J. Arch Intern Med; 1974 Jun 16; 133(6):1017-27. PubMed ID: 4597950 [No Abstract] [Full Text] [Related]
27. The effect of diazoxide on coronary blood flow. Scott JC, Cowley AW. Am J Cardiol; 1969 Dec 16; 24(6):865-9. PubMed ID: 5360240 [No Abstract] [Full Text] [Related]
28. The influences of rate of injection upon the effects of diazoxide. Johnson BF, Kapur M. Am J Med Sci; 1972 Jun 16; 263(6):481-8. PubMed ID: 5050089 [No Abstract] [Full Text] [Related]
29. Vasodilator administration in the presence of beta-adrenergic blockade. Mroczek WJ, Lee WR, Davidov ME, Finnerty FA. Circulation; 1976 Jun 16; 53(6):985-8. PubMed ID: 5209 [Abstract] [Full Text] [Related]
30. Management of severe hypertension with intravenous injections of diazoxide. Miller WE, Gifford RW, Humphrey DC, Vidt DG. Am J Cardiol; 1969 Dec 16; 24(6):870-5. PubMed ID: 5360241 [No Abstract] [Full Text] [Related]
31. [Treatment of acute hypertension during labor with diazoxide. Fetal repercussions]. Martínez P Mendaña J, Hernández García JM, Bralo Ron MT, Gozalo F Lomana MI, de la Fuente P. Acta Obstet Ginecol Hisp Lusit; 1980 May 16; 28(5):315-26. PubMed ID: 7424492 [No Abstract] [Full Text] [Related]
32. [The acute crisis of blood pressure and its treatment in childhood (authors transl)]. Diekmann L. Klin Padiatr; 1975 Mar 16; 187(2):171-5. PubMed ID: 1168289 [Abstract] [Full Text] [Related]
33. Diazoxide in the treatment of hypertension. Nellen M. S Afr Med J; 1970 Jan 31; 44(5):106-8. PubMed ID: 4906221 [No Abstract] [Full Text] [Related]
34. Intravenous diazoxide in treatment of hypertension associated with recent myocardial infarction. O'Brien KP, Grigor RR, Taylor PM. Br Med J; 1975 Oct 11; 4(5988):74-7. PubMed ID: 1182475 [Abstract] [Full Text] [Related]
35. Importance of dissolution rates in producing effective diazoxide blood levels in man. Calesnick B, Katchen B, Black J. J Pharm Sci; 1965 Sep 11; 54(9):1277-80. PubMed ID: 5881220 [No Abstract] [Full Text] [Related]
36. Comparative effects of ethacrynic acid, furosemide, and diazoxide in the perfused dog hindlimb. Ogilvie RI, Schlieper E. Can J Physiol Pharmacol; 1971 Dec 11; 49(12):1038-43. PubMed ID: 5142308 [No Abstract] [Full Text] [Related]
37. Intravenous diazoxide for severe hypertension in childhood. McLaine PN, Drummond KN. J Pediatr; 1971 Nov 11; 79(5):829-32. PubMed ID: 5116710 [No Abstract] [Full Text] [Related]
38. [Changes in plasma volume and electrolytes after treatment of therapy-resistant hypertension with diazoxide and furosemide]. Kiesewetter R, Cebulla P, Herrmann RM, Stoll W. Z Gesamte Inn Med; 1981 Sep 01; 36(17):627-30. PubMed ID: 7345809 [Abstract] [Full Text] [Related]
39. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure. Massie BM, Stern R, Hanlon JT, Haughom F. Am Heart J; 1982 Sep 01; 104(3):581-6. PubMed ID: 7113899 [Abstract] [Full Text] [Related]
40. Oral diazoxide in uncontrolled malignant hypertension. Fang P, MacDonald I, Laver M, Hua A, Kincaid-Smith P. Med J Aust; 1974 Oct 26; 2(17):621-4. PubMed ID: 4444609 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]